Loading...
XNAS
KARD
Market cap1.83bUSD
Jul 31, Last price  
20.82USD
1D
1.71%
Name

Kardigan Inc

Chart & performance

D1W1MN
XNAS:KARD chart
P/E
P/S
EPS
Div yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes. The company was founded by Tassos E. Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, and Elizabeth McNally in August 2023 and is headquartered in Princeton, NJ.
IPO date
Employees
Domiciled in
US
Incorporated in
US

Valuation

No data to show